BIVI CIK: 1580149

BioVie Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
millions USD
FY22:
18.8
FY23:
34.0
FY24:
24.0
FY25:
20.7
FY26:
13.6
(positive)
Change from FY22 to FY26
millions USD
FY22:
1.33
FY23:
1.06
FY24:
1.16
FY25:
0.86
FY26:
0.61
Total assets
Change from FY22 to FY26
millions USD
FY22:
20.1
FY23:
35.1
FY24:
25.2
FY25:
21.6
FY26:
14.3

Liabilities & Equity

(negative)
Change from FY22 to FY26
millions USD
FY22:
4.17
FY23:
14.5
FY24:
9.35
FY25:
2.27
FY26:
3.80
(negative)
Change from FY22 to FY26
millions USD
FY22:
12.3
FY23:
5.27
FY24:
0.35
FY25:
0.28
FY26:
0.18
(positive)
Change from FY22 to FY26
millions USD
FY22:
3.67
FY23:
15.3
FY24:
15.5
FY25:
19.0
FY26:
10.3
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
20.1
FY23:
35.1
FY24:
25.2
FY25:
21.6
FY26:
14.3

All amounts in millions USD Data source:SEC EDGAR